A peptide ligand known as CSG can bind to the laminin-nitrogen complex in the ECM of mouse and human tumors and selectively deliver fusion proteins into the tumor ECM and subsequently trigger the infiltration of potent immune cells while degrading the rigid tumor extracellular matrix, improving nanomedicine uptake and prolonging the survival of tumor-bearing mice 147. This evidence concerns the gene LAMB2 and neoplasm.